October 2023

home / publications / evidence-based-oncology / october-2023

FROM THE EDITOR IN CHIEF: Days of Future Past

Joseph Alvarnas, MD

October 27th 2023

ArticleFROM THE EDITORS

Collaboration Is Key to Execute Value-Based Care for Patients With Cancer

Rose McNulty

October 27th 2023

ArticleIVBM COVERAGE

Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.

Novel Therapies Have Significantly Improved Melanoma Outcomes, With More Exciting Options to Come

Laura Joszt, MA

October 27th 2023

ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine session with Minnesota Oncology.

Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt

Laura Joszt, MA

October 26th 2023

ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.

Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting

Mary Caffrey

October 26th 2023

ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.

Perspectives on EOM: What Makes Sense Moving Forward

Pearl Steinzor;Mary Caffrey

October 25th 2023

ArticleFROM OUR PARTNERS

Business Highlights From Partners in Community Oncology

AJMC Staff

October 25th 2023

ArticleFROM OUR PARTNERS

OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

AJMC Staff

October 25th 2023

ArticleFROM OUR PARTNERS

Coverage in Health Equity: October 2023

Kyle Munz;Skylar Jeremias;Laura Joszt, MA;Maggie L. Shaw

October 21st 2023

Article

Health equity coverage appearing in the October 2023 issue of Evidence-Based Oncology.

Why Failing Faster Is the Key to Accelerating Drug Discovery

Dale Porter, PhD

October 21st 2023

ArticleCOMMENTARY

COVID-19 Fallout on Individuals, Economy, and Health System to Last for Years, White Paper Concludes

Hayden E. Klein

October 20th 2023

Article

The Challenges of Treating Cancer When the Patient Lives Far From Care

Peter Page

October 20th 2023

ArticleCOVER FEATURE

Navigating Decision-Making When Treating Lymphoma With Bispecific Antibodies vs CAR T-Cell Therapy

Ryan Flinn

October 20th 2023

ArticleCOVER FEATURE

[COA seal]: credit: Community Oncology Alliance

COA Supports Bills to Ensure Access to Cancer Medications

AJMC Staff

September 20th 2023

ArticleFROM OUR PARTNERS

The endorsements follow the group's lawsuit earlier this year to overturn CMS' interpretation of the Stark Law.

How AI and Machine Learning Can Bring Quality Improvements in Biopharma

Bryan Abney, MS

August 28th 2023

ArticleCOMMENTARY

A Mission to Cure “All the Cancers”: Crystal Denlinger, MD, FACP, Named CEO of NCCN

Mary Caffrey

August 23rd 2023

ArticleCOVER FEATURE

Denlinger, who spent most of her career at Fox Chase Cancer Center before joining the National Comprehensive Cancer Network (NCCN) as its chief scientific officer, took the helm October 9, 2023.

Unlocking the Benefits of FDA’s Orphan Drug Designation

Rachel Capone, MSHS

August 22nd 2023

ArticleCOMMENTARY

Verily, OneOncology Create Clinical Trial Partnership to Feature Use of SignalPath Across Practices

Mary Caffrey

August 16th 2023

ArticleFROM OUR PARTNERS

Use of SignalPath will improve efficiency, ease compliance, boost enrollment, and ensure financial success in clinical trials, leaders said in interviews.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions